Email Icon Facebook icon Twitter Icon GooglePlus Icon Contact

User Top Menu

Drugs in Trials

Updated 29 December 2016

Important Notice: This information is designed to be used by researchers. Patients and caregivers are directed to consult for more information on how to enroll in specific trials. (See also page on Medications in Development) Neither Schizophrenia Research Forum nor the author(s) of these data will respond to specific questions from the public about the information in this table. Schizophrenia Research Forum does not provide medical advice or promote any product or service. The contents are for informational purposes only and are not intended to substitute for professional medical advice, diagnosis, or treatment. Always seek advice from a qualified physician or health care professional about any medical concern, and do not disregard professional medical advice because of anything you may read on this website.

Created and updated by Hugo Geerts, In Silico Biosciences

View Tables: Drugs in Trials

Hugo Geerts

The overarching goal of these tables is to serve as an unbiased, centralized, publicly available, and regularly updated collection of ongoing clinical trials in schizophrenia. Another important objective is to provide information on studies where reducing clinical symptomatology (i.e., positive, negative, and cognitive deficits) in schizophrenia is a primary goal, rather than trials in which specific co-medications are tested to address drug-specific side effects.

To ensure a high degree of objectivity regarding the content, the tables include only publicly available information, such as that found on or The Stanley Medical Research Institute, in addition to specific company websites.

While we have made every possible effort to correctly represent the data of all trials fulfilling the above criteria, we cannot exclude the possibility that some studies may be cited incorrectly or erroneously excluded. Therefore, we are not able to make any warranty, either expressed or implied, with respect to the functioning and accuracy of these tables. No responsibility is assumed by the authors and curators. If you detect an error in the data or want to submit general concerns, comments, and suggestions about the tables, please contact us

Drug Phases 500

Image courtesy of the National Institutes of Health